ClinicalTrials.gg
Drug

Golidocitinib clinical trials

Also written AZD4205.

studies test it
39
open now
31
in phase 3
5
first study started
2018

How each study uses golidocitinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the golidocitinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Golidocitinib
22
Golidocitinib plus CHOP
2

Development codes

AZD4205
5

Studies by the year they started

39 studies that test it; most in 2025 (13)

Studies that test golidocitinib, by start year
YearStudies
20182
20191
20201
20223
20232
20245
202513
202612

Who runs them

Industry 10 · Other 29

Dizal Pharmaceuticals (10) · Ruijin Hospital (5) · Sun Yat-sen University (4) · Peking Union Medical College Hospital (3) · Peking University Cancer Hospital & Institute (2) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (2) · Fudan University (2) · Beijing Friendship Hospital (2)

Often tested with

Tested in the same studies.

Tucidinostat (6) · Zeprumetostat (2) · Immune checkpoint inhibitors (2) · Sunvozertinib (1) · SINGLE 50 (1) · Adrenal Cortex Hormones (1) · Azacitidine (1) · Selinexor (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 13, 2 in phase 3

Studies that test golidocitinib, phase 3 first.

Studies

Open first, then newest update. How each study uses golidocitinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 39

See all 39 studies that test golidocitinib →

Given beside what is tested · 3 — golidocitinib is usual care or a partner of the new treatment

Codes

What other systems call golidocitinib · ClinicalTrials.gg INT014641

  • UNII (FDA) 3BY9Z3M34GGOLIDOCITINIBConfirmed FDA, Wikidata
  • Wikidata Q131696536golidocitinibConfirmed FDA, Wikidata
  • NCI Thesaurus C156774GolidocitinibOne source FDA
  • DrugBank DB18057One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.